SAFE Study

Giwyn was a partner in the SAFE study. Published in The Lancet, the study reviewed the effectiveness of self-managed abortion with accompaniment support. We followed the experience of women in Argentina and Nigeria who requested information on self-managed medication abortion. Participants used misoprostol alone or with mifepristone.

 

The study found that self-managed medication abortion with accompaniment support was highly effective. We found it was just as effective as clinician-managed medication abortion for pregnancies less than 9 weeks.